Lawstreet Journal

Zydus Cadila signs pact to market Taiwan’s TLC’s Black Fungus drugs in India

Lawstreet Journal 28 May 2021 5:58pm

Image courtesy: Lawstreet Journal Business Zydus Cadila signs pact to market Taiwan’s TLC’s Black Fungus drugs in India

Zydus Cadila and Taiwanese speciality pharma company TLC have signed a pact to market Liposomal Amphotericin B, a critical drug for treating Black Fungus disease in India.

The drug will be commercialised in India under the name ‘AmphoTLC’ in the form of 50 mg injections.

Cadila healthcare MD Sharvil Patel said that the company was attempting to immediately make the drug available in India, considering the acute shortage of drugs to treat mucormycosis. He also emphasised the significance of a safe and effective drug for the treatment of life-threatening disease.

George Yeh, President of TLC, also promised immediate delivery of the new drug to India.

Zydus Cadila will be engaged as a non-exclusive distributor of the drug in India. The drugs will be manufactured by TLC and handed over to Zydus Cadila.

The Central Drug Standards Control Organisation has approved the importation and use of the new drug.

AmphoTLC is said to be effective against severe systemic fungal infections of the nature of mucormycosis.

India has witnessed a rising number of black fungus disease as a side effect of treatment of Covid-19 in patients with co-morbidities. The infection is seen in severe Covid-19 patients who were treated with steroids.

On Thursday (27/05/2021), the Delhi government had declared mucormycosis as a notified disease under the Epidemic Diseases Act, 1897.

The official notification of the Delhi Government states that black fungus disease is a severe infection that ordinary provisions of law cannot contain.

The notification provides that all hospitals in the… Continue Reading...

Tagged: Zydus   TLC   Corona Updates  
Disclaimer: SoOLEGAL in Media collaboration with Lawstreet Journal. SoOLEGAL take no responsbility for the content provided by Lawstreet Journal. For any discrepancies Contact Lawstreet Journal.
Did you find this write up useful? YES 0 NO 0

C2RMTo Know More

Something Awesome Is In The Work









Sign-up and we will notify you of our launch.
We’ll also give some discount for your effort :)

* We won’t use your email for spam, just to notify you of our launch.

SAARTHTo Know More

Launching Soon : SAARTH, your complete client, case, practise & document management SAAS application with direct client chat feature.

If you want to know more give us a Call at :+91 98109 29455 or Mail